Updated Jul 16, 2026
Burns Thomas William has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $31.62M.
Thomas William Burns is the Chairman and CEO of Glaukos Corp, a company specializing in ophthalmic pharmaceuticals and medical technology. He has also held significant roles at Pulmonx Corp, contributing to advancements in medical treatments.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-29 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 4.1K | $142.57 | $579K |
| 2026-06-09 | LUNG | Pulmonx Corp | A — Grant or award | 40.0K | $0.00 | |
| 2026-04-04 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 7.5K | $109.60 | $818K |
| 2026-04-04 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 2.5K | $109.60 | $271K |
| 2026-04-04 | GKOS | GLAUKOS Corp | G — Bona-fide gift | 180.3K | $0.00 | |
| 2026-04-04 | GKOS | GLAUKOS Corp | G — Bona-fide gift | 180.3K | $0.00 | |
| 2026-03-28 | GKOS | GLAUKOS Corp | A — Grant or award | 14.2K | $0.00 | |
| 2026-03-28 | GKOS | GLAUKOS Corp | A — Grant or award | 9.4K | $0.00 | |
| 2026-03-26 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 2.7K | $105.23 | $289K |
| 2026-03-19 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 2.8K | $98.94 | $277K |
| 2026-03-18 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 5.2K | $97.02 | $506K |
| 2026-03-09 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 1.1K | $112.10 | $123K |
| 2026-02-26 | GKOS | GLAUKOS Corp | F — Tax withholding / forfeiture | 4.1K | $119.17 | $484K |
| 2026-02-11 | GKOS | GLAUKOS Corp | M — Option exercise | 166.0K | $30.92 | $5.13M |
| 2026-02-11 | GKOS | GLAUKOS Corp | G — Bona-fide gift | 67.4K | $0.00 | |
| 2026-02-11 | GKOS | GLAUKOS Corp | G — Bona-fide gift | 67.4K | $0.00 | |
| 2026-01-20 | GKOS | GLAUKOS Corp | S — Open-market sale [10b5-1] | 186.9K | $115.00 | $21.50M |
| 2026-01-20 | GKOS | GLAUKOS Corp | M — Option exercise [10b5-1] | 186.9K | $16.49 | $3.08M |
| 2026-01-20 | GKOS | GLAUKOS Corp | S — Open-market sale [10b5-1] | 88.1K | $115.00 | $10.13M |
| 2026-01-20 | GKOS | GLAUKOS Corp | M — Option exercise [10b5-1] | 88.1K | $16.49 | $1.45M |
Thomas William Burns is the Chairman and CEO of Glaukos Corp, a company specializing in ophthalmic pharmaceuticals and medical technology. He has also held significant roles at Pulmonx Corp, contributing to advancements in medical treatments.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($31.62M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Burns Thomas William profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.